Skip to Main Content

Calgary Scientists to Create Human ‘Neurochip’

The science fiction of melding man and machine has played out for decades onscreen, from The Six Million Dollar Man to The Terminator. But the bionic hybrid age may well be flickering to life –

U of T Spinoff Company Inks its Third Agreement

University of Toronto spinoff company Interface Biologics Inc. has announced the signing of an evaluation and exclusive license option agreement with Fresenius Medical Care, the world’s largest

Artery-on-a-Chip Studies Heart Disease

Professor Axel Guenther (MIE, IBBME) and colleagues have developed a microfluidic platform on which fragile blood vessels can be fixed, allowing the factors that promote and sustain cardiovascular